Comparison of a Non-Invasive Central Venous Pressure Device and Physical Examination in Patients With Chronic Kidney Disease

Sponsor
Mespere Lifesciences Inc. (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT01243515
Collaborator
St. Joseph's Healthcare Hamilton (Other)
0
1

Study Details

Study Description

Brief Summary

The primary objective of this study is to determine whether a correlation exists between the Mespere Non-Invasive Central Venous Pressure (NICVP) device for measuring central venous pressure (CVP), and assessment of CVP via physical examination.

Condition or Disease Intervention/Treatment Phase
  • Device: Non-Invasive Central Venous Pressure monitor
  • Procedure: Physical examination of jugular vein

Detailed Description

The estimation of central venous pressure (CVP) is part of routine clinical examination. Central venous pressure is the indication of the pressure in the right atrium of the heart and it can be measured by determining the height of the blood column in the internal or external jugular vein. Clinical use of CVP has a wide range of applications including diagnosis of heart failure, pleural effusion, hypervolemia, hypovolemia, and sepsis. The standard clinical method for attaining CVP non-invasively is the physical examination of jugular venous pulse (JVP). The JVP provides a useful estimate of the CVP.

It is often difficult to identify the internal jugular vein to determine the JVP. The internal jugular vein is deep and adjacent to the carotid artery and pulsations derived from the artery may obscure the subtle venous pulsations. Manoeuvres to differentiate carotid pulsation and jugular pulsation are helpful in identifying the internal jugular vein, however determining the JVP based on the internal jugular vein examination is difficult.

Examination of the external jugular vein to determine JVP is an appealing alternative. The external jugular vein is easier to visualize and studies have demonstrated that this is a reliable method that correlates highly with catheter measured CVP.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Clinical Validation of a Non-Invasive Central Venous Pressure Device in Comparison With Physical Examination in Patients With Chronic Kidney Disease and Healthy Volunteers

Arms and Interventions

Arm Intervention/Treatment
Chronic Kidney Disease

minimum 7 subjects (male and female)

Device: Non-Invasive Central Venous Pressure monitor
An adhesive patch (connected to the Mespere NICVP monitor) is placed on the neck of the subject, to determine if the CVP values displayed by the device correlates with CVP values obtained by physical examination (standard clinical practice)
Other Names:
  • NICVP monitor
  • Procedure: Physical examination of jugular vein
    Physicians assess CVP using the jugular vein of the subject

    Healthy subjects

    minimum 3 subjects (male and female)

    Device: Non-Invasive Central Venous Pressure monitor
    An adhesive patch (connected to the Mespere NICVP monitor) is placed on the neck of the subject, to determine if the CVP values displayed by the device correlates with CVP values obtained by physical examination (standard clinical practice)
    Other Names:
  • NICVP monitor
  • Procedure: Physical examination of jugular vein
    Physicians assess CVP using the jugular vein of the subject

    Outcome Measures

    Primary Outcome Measures

    1. Central Venous Pressure (CVP) [0-3 hours]

      To determine if the CVP from the non-invasive monitor correlates with the CVP from physical examination

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age 18 years or older at the time of enrolment

    • Chronic Kidney Disease patients and healthy volunteers

    • Participants should be able to provide written informed consent

    • Subject is termed eligible as determined by Pre-Screening Phase (as defined in protocol)

    Exclusion Criteria:
    • Unable to identify external jugular vein (EJV)

    • Unable to identify internal jugular vein (IJV)

    • Unable to access right side of subject's neck

    • Allergic to adhesive tape

    • History of central vein stenosis

    • Undergoing photodynamic therapy (PDT)

    • Presence of an arteriovenous fistula

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Joseph's Hamilton Healthcare Hamilton Ontario Canada L8N 4A6

    Sponsors and Collaborators

    • Mespere Lifesciences Inc.
    • St. Joseph's Healthcare Hamilton

    Investigators

    • Principal Investigator: Azim S Gangji, MD, St. Joseph's Healthcare Hamilton
    • Study Director: Melissa T Perri, MESc, Mespere Lifesciences Inc.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mespere Lifesciences Inc.
    ClinicalTrials.gov Identifier:
    NCT01243515
    Other Study ID Numbers:
    • MLS STP-9000006
    First Posted:
    Nov 18, 2010
    Last Update Posted:
    Feb 8, 2013
    Last Verified:
    Feb 1, 2013

    Study Results

    No Results Posted as of Feb 8, 2013